Adverse events after vaccination in children under 06 years in Amapá: a discriptive analysis
DOI:
https://doi.org/10.33448/rsd-v11i6.29256Keywords:
Vaccines; Adverse Event; Child Health; Health Information Systems.Abstract
Introduction: Immunization is an effective health strategy, especially in children, being adopted by the Brazilian health system. With the increase in vaccination, the possibility of post-vaccination adverse events (AEPV) increases, with mandatory notification in Brazil, when severe or when there is death. Objective: to analyze the AEFI notified in the SI-EAPV, in the State of Amapá, in children under 06 years old, between the years 2015 and 2017. Methodology: exploratory, descriptive, quantitative and comparative research of the AEFI using data from the SI-EAPV, between 01/01/2015 and 12/31/2017. Results: There were 04 notified cases, 50% EANG, 25% EAG and 25% were not related to immunization. The vaccine most related to EAPV was the Pentavalent. The average age of 07 months was observed for the reported cases. Fever was the only sign/symptom reported in all cases. Conclusion: The amounts of AEFI notified in the system in the State are lower than those noticed in other regions, with underreporting observed.
References
Amato Neto, V., Ballalai, I., Bricks, L. F., Levi, M., Wagner, N. H. C. V., & Kfouri, R. de Á. (2011). Atualizações, orientações, sugestões: imunizações. São Paulo: Segmento Farma.
Araújo, T. M. E. de, Carvalho, P. M. G. de, & Vieira, R. D. F. (2007). Análise dos eventos adversos pós-vacinais ocorridos em Teresina. Revista Brasileira de Enfermagem, 60(4), 444–448. https://doi.org/10.1590/s0034-71672007000400016
Barreto, M. L., Teixeira, M. G., Bastos, F. I., Ximenes, R. A., Barata, R. B., & Rodrigues, L. C. (2011). Successes and failures in the control of infectious diseases in Brazil: Social and environmental context, policies, interventions, and research needs. The Lancet, 377(9780), 1877–1889. https://doi.org/10.1016/S0140-6736(11)60202-X
Brasil. (2013). Programa Nacional de Imunizações (PNI) : 40 anos. In Biblioteca Virtual em Saúde do Ministério da Saúde. http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf
Brasil. (2014a). Ministério da Saúde. Manual de Normas e Procedimentos para Vacinação.
Brasil. Ministério da Saúde. (2014b). Manual de Vigilância Epidemiológica de Eventos Adversos Pós-Vacinação. http://editora.saude.gov.br
Butantan (2021). Ensaios Clínicos. https://butantan.gov.br/pesquisa/ensaios-clinicos
Chen, R. T. (1999). Vaccine risks: Real, perceived and unknown. Vaccine, 17(SUPPL. 3), 41–46. https://doi.org/10.1016/S0264-410X(99)00292-3
Cunha, M. P. L., Dórea, J. G., Marques, R. C., & Leão, R. S. (2013). Vaccine adverse events reported during the first ten years (1998-2008) after introduction in the state of Rondonia, Brazil. BioMed Research International, 2013. https://doi.org/10.1155/2013/853083
Curran, J. W., & Jaffe, H. W. (2011). Public Health Then and Now: Celebrating 50 Years of MMWR at CDC. MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries / CDC, 60 Suppl 4, 64–69.
Hochman, B., Nahas, F. X., Filho, R. S. de O., & Ferreira, L. M. (2005). Desenhos de pesquisa. Acta Cirúrgica Brasileira, 20(3), 02–09. http://www.scielo.br/acb
Minayo, M. C. de S., & Sanches, O. (1993). Quantitativo-qualitativo: oposição ou complementaridade? Cadernos de Saúde Pública, 9(3), 237–248. https://doi.org/10.1590/s0102-311x1993000300002
Moura, A. D. A., Costa, A. S. da, Braga, A. V. L., Bastos, E. C. da S. A., Lima, G. G. de, & Chaves, E. S. (2015). Vigilância de eventos adversos pós-vacinação no estado do Ceará, em 2011. Epidemiologia e Serviços de Saúde, 24(1), 1032–1041. https://doi.org/10.5123/s1679-49742015000100017
Pacheco, F., Domingues, C., Maranhão, A., Carvalho, S., Teixeira, A., Braz, R., Rebelo, R., & Guilhem, D. (2018). Análise do Sistema de Informação da Vigilância de Eventos Adversos Pós-Vacinação no Brasil, 2014 a 2016. Revista Panamericana de Salud Pública, 1–8. https://doi.org/10.26633/rpsp.2018.12
Ponte, C. F. (2003). Vacinação, controle de qualidade e produção de vacinas no Brasil a partir de 1960. História, Ciências, Saúde-Manguinhos, 10(suppl 2), 619–653. https://doi.org/10.1590/s0104-59702003000500009
Sato, A. P. S., Ferreira, V. L. de R., Tauil, M. de C., Rodrigues, L. C., Barros, M. B., Martineli, E., Costa, Â. A., Inenami, M., & Waldman, E. A. (2018). Uso de registro informatizado de imunização na vigilância de eventos adversos pós-vacina. Revista de Saúde Pública, 52, 4. https://doi.org/10.11606/s1518-8787.2018052000295
Silva, S. S., Oliveira, V. C. de, Ribeiro, H. C. T. C., Alves, T. G. S., Cavalcante, R. B., & Guimarães, E. A. de A. (2016). Análise dos eventos adversos após aplicação de vacinas em Minas Gerais, 2011: um estudo transversal. Epidemiologia e Servicos de Saude : Revista Do Sistema Unico de Saude Do Brasil, 25(1), 45–54. https://doi.org/10.5123/S1679-49742016000100005
Stratton, K., Ford, A., Rusch, E., & Clayton, E. W. (2012). Adverse effects of vaccines: Evidence and causality. Adverse Effects of Vaccines: Evidence and Causality, 1–894. https://doi.org/10.17226/13164
Temporão, J. G. (2003). O Programa Nacional de Imunizações (PNI): origens e desenvolvimento. História, Ciências, Saúde-Manguinhos, 10(suppl 2), 601–617. https://doi.org/10.1590/s0104-59702003000500008
Trollfors, B. (2010). Red Book: 2009 Report of the Committee on Infectious Disease. In Acta Paediatrica (Vol. 99, Issue 3). https://doi.org/10.1111/j.1651-2227.2009.01642.x
WHO (2021). Vaccines and immunization: What is vaccination? https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-what-is-vaccination?
WHO (2012). Definitions and Applications of Terms for Vaccine Pharmacovigilance
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Marcelo Gladson Pires; Wanda Pereira Goes dos Santos; Rosilene Ferreira Cardoso
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
